70.9 F
New York
70.9 F
New York
Wednesday, August 4, 2021

Fanuc has produced its 750,000th robot

- Advertisement -spot_img

Fanuc has manufactured its 750,000th industrial robot, which is thought to be more than any other manufacturer in this segment.

At present, Fanuc produces around 8,000 industrial robots every month at its factories in Japan, although monthly capacity is available up to 11,000 units. The company is known for its highly automated production facilities, where thousands of robots demonstrate reliability, dexterity and speed in the build of Fanuc products that include robots, controllers and machine tools.

Fanuc’s largest customer group are car producers and their suppliers, although manufacturers from other industries, such as electronics, food, pharmaceutical and medical, are also growing their base of industrial robots.

While the coronavirus pandemic initially led to a decline in robot orders, Fanuc has since witnessed a strong rebound in sales, especially from Asia and the US.

“In Europe, the recovery has truly begun,” said Shinichi Tanzawa, president and CEO of Fanuc Europe Corporation. “Although Fanuc’s overall order intake for robots in Europe increased only slightly during the past fiscal year, sales in the past few months are at a historical high.”

Fanuc is pursuing ambitious plans in Europe, where the company is steadily expanding its sales and service network. In the past four years alone, Fanuc has invested more than €120 million in new facilities across Europe. Further underpinning its growth plans, the company will invest another €100 million in the coming three years.

Mr Tanzawa added: “We are confident that the trend towards robotization will grow further and that FANUC robots will help customers to automate their manufacturing plants and save cost like FANUC does at its own factories. We will do everything necessary to support our customers in these endeavours.”

Fanuc
www.fanuc.eu/uk/en

Disclaimer: This article is for informational purposes only. It is not a direct offer or solicitation of an offer to buy or sell, or a recommendation or endorsement of any products, services, or companies. OTCBBStockNews.com does not provide investment, tax, legal, or accounting advice. Neither the company nor the author is responsible, directly or indirectly, for any damage or loss caused or alleged to be caused by or in connection with the use of or reliance on any content, goods or services mentioned in this article.

- Advertisement -spot_img
Leonard Howard
After finishing his MBA from a top-ranked university Leonard joined OTC to pursue his passion which is writing. He is currently covering the industrial sector.
spot_img

Latest news

- Advertisement -spot_img

Related news

- Advertisement -spot_img
Subscribe to our newsletter.We never spam.